Exothera

Jumet, BE
Find alternatives to Exothera for AAV →
Program data pending ClinicalTrials.gov matching · Last scored 2026-10-29
78.1
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ✓ EMA GMP (4) ○ MHRA GMP

Quick Facts: Exothera

Signal Score
78.1/100 (as of 2026-10-29)
Quality Compliance
100.0/100 — Clean EMA record: 4 active GMP certificates (no deductions)
Headquarters
Jumet, BE
Modalities
AAV, Adenoviral, Lentiviral
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Exothera

Belgian viral vector CDMO.

Signal Score & Pillar Breakdown

Quality Compliance 100.0
Clean EMA record: 4 active GMP certificates (no deductions)
Sources: FDA Data Dashboard, EMA EudraGMDP
Clean EMA record: 4 active GMP certificates (no deductions)
FDA InspectionsNo US records on file
EMA GMP Certificates4 on record
Clean EMA record: 4 active GMP certificates (no deductions)
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesAAV, Adenoviral, Lentiviral
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 58.0
1 manufacturing site: Jumet, Belgium
Modalities: AAV, Adenoviral, Lentiviral
Capacity assessment: 58.0/100
Sites: Jumet, Belgium
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
1 manufacturing site: Jumet, Belgium
Modalities: AAV, Adenoviral, Lentiviral
Capacity assessment: 58.0/100

Exothera EMA GMP Compliance 4 certificates

2023-11
2023-11
2023-11
2023-11
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
BE/GMP/2023/128 Exothera Belgium 2023-11-24 COMPLIANT
BE/GMP/2023/129 Exothera Belgium 2023-11-24 COMPLIANT
BE/GMP/2023/131 Exothera Belgium 2023-11-24 COMPLIANT
BE/GMP/2023/130 Exothera Belgium 2023-11-24 COMPLIANT
Source: EMA EudraGMDP · Retrieved Nov 21, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data. This company's careers site asks automated readers not to collect it (robots.txt), and we respect that.
Source: public careers pages · Checked Nov 20, 2026

Frequently Asked Questions About Exothera

Does Exothera hold EMA or MHRA GMP certificates?
CDMO Signal tracks 4 EMA GMP certificates for Exothera.
What is Exothera's CDMO Signal Score?
Exothera has a Signal Score of 78/100, based on quality, operations, financial stability, and capacity data.
Evaluating Exothera for a manufacturing program?
Use the free AI matchmaker to compare Exothera against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs → Adenoviral CDMOs → Lentiviral CDMOs →

Similar CDMOs

SK pharmteco
Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
Signal Score: 79.5
Viral Vectors, AAV, Lentiviral, Adenoviral, HPAPIs, Small Molecules, Peptides, BioCatalysis, Chromatography, Cell Therapy
Advent Bioservices
London, United Kingdom
Signal Score: 78.1
AAV, Lentiviral, Adenoviral
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 77.6
AAV, Lentiviral, Plasmid DNA, Adenoviral, Plasmid, Small Molecule API, Oral Solid Dose, Sterile Fill-Finish
Rose BioSolutions
Rockville, MD · Memphis, TN · Keele, United Kingdom
Signal Score: 64.0
AAV, Lentiviral, Adenoviral, Plasmid, Cell Therapy, CAR-T
Pharmaron
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars

Compare Exothera with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Exothera
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.